Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay?

Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.

Source: NYT Health - December 7, 2019 Category: Consumer Health News Authors: Gina Kolata Tags: Drugs (Pharmaceuticals) Health Insurance and Managed Care Sickle Cell Anemia Prices (Fares, Fees and Rates) Stroke Clinical Trials Hemoglobin Food and Drug Administration Novartis AG Global Blood Therapeutics Source Type: news